Table 1. Tumour samples.

ID	Source	Primary diagnosis	ER, PR, HER2 status
HCI-001	Breast tumour	IDC	−/−/−
HCI-002	Breast tumour	IDC	−/−/−
HCI-003	Breast tumour	IDC	+/+/−
HCI-005	Pleural effusion	IDC and ILC	+/+/+
HCI-006	Pleural effusion	—	+/+/+
HCI-007	Pleural effusion	IBC	+/+/+
HCI-008	Pleural effusion	Poorly differentiated adenocarcinoma	−/−/+
HCI-009	Ascites	Poorly differentiated adenocarcinoma	−/−/−
HCI-010	Pleural effusion	IDC	−/−/−
HCI-011	Pleural effusion	IDC	+/+/−
HCI-012	Pleural effusion	IDC	−/−/+
HCI-013	Breast tumour	—	+/+/−

IBC, inflammatory breast cancer; IDC, infiltrating ductal carcinoma; ILC, infiltrating lobular carcinoma.

Table describing the names (IDs) of 12 human tumour samples, their source, primary diagnosis, oestrogen receptor (ER), progesterone receptor (PR) and HER2 status (also see DeRose et al.²⁷).